Abstract
To determine the association between overall survival (OS) and two other endpoints, progression-free survival (PFS) and time to treatment failure (TTF), for patients with previously untreated advanced renal cell carcinoma. We used individual patient data from the intent-to-treat population (n=1096) in the CheckMate 214 study.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
